Educational Wellness Information Only
This platform provides peer-reviewed research summaries and educational content about peptides for wellness and optimization purposes. Nothing on this site is intended as medical advice, diagnosis, or treatment. We do not claim any peptide can diagnose, treat, cure, or prevent any disease. Always consult a licensed healthcare provider before beginning any wellness protocol.
Statements on this site have not been evaluated by the FDA. Compounded preparations are subject to applicable state and federal regulations. Availability and eligibility vary.
Sincalide (Kinevac) vs Vasopressin (Vasostrict)
An educational, source-based comparison of Sincalide (Kinevac) and Vasopressin (Vasostrict) — how each peptide works, what it's researched for, and what to know before going deeper.
Synthetic C-terminal octapeptide of cholecystokinin for gallbladder imaging.
Synthetic CCK-8 that binds CCK-A receptors on gallbladder smooth muscle, triggering contraction; used to assess gallbladder ejection fraction in cholescintigraphy.
- Gallbladder ejection fraction (HIDA scan)
- Pancreatic secretion testing
- Small bowel transit imaging
- • FDA-approved.
- • Abdominal cramping, nausea, diarrhea common; contraindicated in suspected gallstone obstruction.
Endogenous nonapeptide that activates V1 vascular receptors to cause vasoconstriction and V2 renal receptors for water reabsorption. Used to raise blood pressure in catecholamine-resistant shock.
- Septic shock
- Cardiac arrest (historical)
- Diabetes insipidus
- • FDA-approved.
- • Ischemic complications possible at high doses.
Sincalide (Kinevac) vs Vasopressin (Vasostrict) — Key differences
- Class: Sincalide (Kinevac) is classified as CCK Analog · Diagnostics, while Vasopressin (Vasostrict) is Vasopressor · Hormonal.
- Primary research focus: Sincalide (Kinevac) — gallbladder ejection fraction (hida scan); Vasopressin (Vasostrict) — septic shock.
- Tag: FDA-Approved · Diagnostics vs FDA-Approved · Critical Care.